Genex Pharmaceutical, Inc. (GENX)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0001 - Volume
10,000 - Avg. Volume
0 - Market Cap (intraday)
110,643 - Beta (5Y Monthly) -39.01
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin City, the People's Republic of China.
86
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: GENX
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GENX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GENX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.03
Enterprise Value/EBITDA
0.15
Financial Highlights
Profitability and Income Statement
Profit Margin
10.58%
Return on Assets (ttm)
4.05%
Return on Equity (ttm)
7.78%
Revenue (ttm)
3.24M
Net Income Avi to Common (ttm)
342.55k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
430.12k
Total Debt/Equity (mrq)
12.13%
Levered Free Cash Flow (ttm)
1.25M
Company Insights: GENX
GENX does not have Company Insights